The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Buprenorphine Hydrochloride-Global Market Insights and Sales Trends 2025
Synopsis
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
The global Buprenorphine Hydrochloride market size is expected to reach US$ 158.3 million by 2029, growing at a CAGR of 1.9% from 2023 to 2029. The market is mainly driven by the significant applications of Buprenorphine Hydrochloride in various end use industries. The expanding demands from the Analgesic and Opioid Antagonist, are propelling Buprenorphine Hydrochloride market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.
The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Buprenorphine Hydrochloride, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Buprenorphine Hydrochloride market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Buprenorphine Hydrochloride market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Buprenorphine Hydrochloride sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Buprenorphine Hydrochloride covered in this report include Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs and Sun Pharma, etc.
The global Buprenorphine Hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Global Buprenorphine Hydrochloride market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Buprenorphine Hydrochloride market, Segment by Type:
Tablets
Injection
Global Buprenorphine Hydrochloride market, by Application
Analgesic
Opioid Antagonist
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Buprenorphine Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Buprenorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
The global Buprenorphine Hydrochloride market size is expected to reach US$ 158.3 million by 2029, growing at a CAGR of 1.9% from 2023 to 2029. The market is mainly driven by the significant applications of Buprenorphine Hydrochloride in various end use industries. The expanding demands from the Analgesic and Opioid Antagonist, are propelling Buprenorphine Hydrochloride market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.
The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Buprenorphine Hydrochloride, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Buprenorphine Hydrochloride market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Buprenorphine Hydrochloride market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Buprenorphine Hydrochloride sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Buprenorphine Hydrochloride covered in this report include Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs and Sun Pharma, etc.
The global Buprenorphine Hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Global Buprenorphine Hydrochloride market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Buprenorphine Hydrochloride market, Segment by Type:
Tablets
Injection
Global Buprenorphine Hydrochloride market, by Application
Analgesic
Opioid Antagonist
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Buprenorphine Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Buprenorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Buprenorphine Hydrochloride Market Overview
1.1 Buprenorphine Hydrochloride Product Overview
1.2 Buprenorphine Hydrochloride Market Segment by Type
1.2.1 Tablets
1.2.2 Injection
1.3 Global Buprenorphine Hydrochloride Market Size by Type
1.3.1 Global Buprenorphine Hydrochloride Market Size Overview by Type (2018-2029)
1.3.2 Global Buprenorphine Hydrochloride Historic Market Size Review by Type (2018-2023)
1.3.3 Global Buprenorphine Hydrochloride Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Buprenorphine Hydrochloride Sales Breakdown by Type (2018-2023)
1.4.2 Europe Buprenorphine Hydrochloride Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Buprenorphine Hydrochloride Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Buprenorphine Hydrochloride Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Buprenorphine Hydrochloride Sales Breakdown by Type (2018-2023)
2 Global Buprenorphine Hydrochloride Market Competition by Company
2.1 Global Top Players by Buprenorphine Hydrochloride Sales (2018-2023)
2.2 Global Top Players by Buprenorphine Hydrochloride Revenue (2018-2023)
2.3 Global Top Players by Buprenorphine Hydrochloride Price (2018-2023)
2.4 Global Top Manufacturers Buprenorphine Hydrochloride Manufacturing Base Distribution, Sales Area, Product Type
2.5 Buprenorphine Hydrochloride Market Competitive Situation and Trends
2.5.1 Buprenorphine Hydrochloride Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Buprenorphine Hydrochloride Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Buprenorphine Hydrochloride as of 2022)
2.7 Date of Key Manufacturers Enter into Buprenorphine Hydrochloride Market
2.8 Key Manufacturers Buprenorphine Hydrochloride Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Buprenorphine Hydrochloride Status and Outlook by Region
3.1 Global Buprenorphine Hydrochloride Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Buprenorphine Hydrochloride Historic Market Size by Region
3.2.1 Global Buprenorphine Hydrochloride Sales in Volume by Region (2018-2023)
3.2.2 Global Buprenorphine Hydrochloride Sales in Value by Region (2018-2023)
3.2.3 Global Buprenorphine Hydrochloride Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Buprenorphine Hydrochloride Forecasted Market Size by Region
3.3.1 Global Buprenorphine Hydrochloride Sales in Volume by Region (2024-2029)
3.3.2 Global Buprenorphine Hydrochloride Sales in Value by Region (2024-2029)
3.3.3 Global Buprenorphine Hydrochloride Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Buprenorphine Hydrochloride by Application
4.1 Buprenorphine Hydrochloride Market Segment by Application
4.1.1 Analgesic
4.1.2 Opioid Antagonist
4.2 Global Buprenorphine Hydrochloride Market Size by Application
4.2.1 Global Buprenorphine Hydrochloride Market Size Overview by Application (2018-2029)
4.2.2 Global Buprenorphine Hydrochloride Historic Market Size Review by Application (2018-2023)
4.2.3 Global Buprenorphine Hydrochloride Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Buprenorphine Hydrochloride Sales Breakdown by Application (2018-2023)
4.3.2 Europe Buprenorphine Hydrochloride Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Buprenorphine Hydrochloride Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Buprenorphine Hydrochloride Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Buprenorphine Hydrochloride Sales Breakdown by Application (2018-2023)
5 North America Buprenorphine Hydrochloride by Country
5.1 North America Buprenorphine Hydrochloride Historic Market Size by Country
5.1.1 North America Buprenorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Buprenorphine Hydrochloride Sales in Volume by Country (2018-2023)
5.1.3 North America Buprenorphine Hydrochloride Sales in Value by Country (2018-2023)
5.2 North America Buprenorphine Hydrochloride Forecasted Market Size by Country
5.2.1 North America Buprenorphine Hydrochloride Sales in Volume by Country (2024-2029)
5.2.2 North America Buprenorphine Hydrochloride Sales in Value by Country (2024-2029)
6 Europe Buprenorphine Hydrochloride by Country
6.1 Europe Buprenorphine Hydrochloride Historic Market Size by Country
6.1.1 Europe Buprenorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Buprenorphine Hydrochloride Sales in Volume by Country (2018-2023)
6.1.3 Europe Buprenorphine Hydrochloride Sales in Value by Country (2018-2023)
6.2 Europe Buprenorphine Hydrochloride Forecasted Market Size by Country
6.2.1 Europe Buprenorphine Hydrochloride Sales in Volume by Country (2024-2029)
6.2.2 Europe Buprenorphine Hydrochloride Sales in Value by Country (2024-2029)
7 Asia-Pacific Buprenorphine Hydrochloride by Region
7.1 Asia-Pacific Buprenorphine Hydrochloride Historic Market Size by Region
7.1.1 Asia-Pacific Buprenorphine Hydrochloride Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Buprenorphine Hydrochloride Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Buprenorphine Hydrochloride Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Buprenorphine Hydrochloride Forecasted Market Size by Region
7.2.1 Asia-Pacific Buprenorphine Hydrochloride Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Buprenorphine Hydrochloride Sales in Value by Region (2024-2029)
8 Latin America Buprenorphine Hydrochloride by Country
8.1 Latin America Buprenorphine Hydrochloride Historic Market Size by Country
8.1.1 Latin America Buprenorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Buprenorphine Hydrochloride Sales in Volume by Country (2018-2023)
8.1.3 Latin America Buprenorphine Hydrochloride Sales in Value by Country (2018-2023)
8.2 Latin America Buprenorphine Hydrochloride Forecasted Market Size by Country
8.2.1 Latin America Buprenorphine Hydrochloride Sales in Volume by Country (2024-2029)
8.2.2 Latin America Buprenorphine Hydrochloride Sales in Value by Country (2024-2029)
9 Middle East and Africa Buprenorphine Hydrochloride by Country
9.1 Middle East and Africa Buprenorphine Hydrochloride Historic Market Size by Country
9.1.1 Middle East and Africa Buprenorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Buprenorphine Hydrochloride Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Buprenorphine Hydrochloride Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Buprenorphine Hydrochloride Forecasted Market Size by Country
9.2.1 Middle East and Africa Buprenorphine Hydrochloride Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Buprenorphine Hydrochloride Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Siegfried
10.1.1 Siegfried Company Information
10.1.2 Siegfried Introduction and Business Overview
10.1.3 Siegfried Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Siegfried Buprenorphine Hydrochloride Products Offered
10.1.5 Siegfried Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Buprenorphine Hydrochloride Products Offered
10.2.5 Sanofi Recent Development
10.3 Johnson Matthey
10.3.1 Johnson Matthey Company Information
10.3.2 Johnson Matthey Introduction and Business Overview
10.3.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Johnson Matthey Buprenorphine Hydrochloride Products Offered
10.3.5 Johnson Matthey Recent Development
10.4 Mallinckrodt
10.4.1 Mallinckrodt Company Information
10.4.2 Mallinckrodt Introduction and Business Overview
10.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mallinckrodt Buprenorphine Hydrochloride Products Offered
10.4.5 Mallinckrodt Recent Development
10.5 Noramco
10.5.1 Noramco Company Information
10.5.2 Noramco Introduction and Business Overview
10.5.3 Noramco Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Noramco Buprenorphine Hydrochloride Products Offered
10.5.5 Noramco Recent Development
10.6 Unichemlabs
10.6.1 Unichemlabs Company Information
10.6.2 Unichemlabs Introduction and Business Overview
10.6.3 Unichemlabs Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Unichemlabs Buprenorphine Hydrochloride Products Offered
10.6.5 Unichemlabs Recent Development
10.7 Arevipharma
10.7.1 Arevipharma Company Information
10.7.2 Arevipharma Introduction and Business Overview
10.7.3 Arevipharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Arevipharma Buprenorphine Hydrochloride Products Offered
10.7.5 Arevipharma Recent Development
10.8 Resonance-labs
10.8.1 Resonance-labs Company Information
10.8.2 Resonance-labs Introduction and Business Overview
10.8.3 Resonance-labs Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Resonance-labs Buprenorphine Hydrochloride Products Offered
10.8.5 Resonance-labs Recent Development
10.9 Sun Pharma
10.9.1 Sun Pharma Company Information
10.9.2 Sun Pharma Introduction and Business Overview
10.9.3 Sun Pharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sun Pharma Buprenorphine Hydrochloride Products Offered
10.9.5 Sun Pharma Recent Development
10.10 Rusan Pharma
10.10.1 Rusan Pharma Company Information
10.10.2 Rusan Pharma Introduction and Business Overview
10.10.3 Rusan Pharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Rusan Pharma Buprenorphine Hydrochloride Products Offered
10.10.5 Rusan Pharma Recent Development
10.11 Micro Orgo Chem
10.11.1 Micro Orgo Chem Company Information
10.11.2 Micro Orgo Chem Introduction and Business Overview
10.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Micro Orgo Chem Buprenorphine Hydrochloride Products Offered
10.11.5 Micro Orgo Chem Recent Development
10.12 Faranshimi
10.12.1 Faranshimi Company Information
10.12.2 Faranshimi Introduction and Business Overview
10.12.3 Faranshimi Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Faranshimi Buprenorphine Hydrochloride Products Offered
10.12.5 Faranshimi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Buprenorphine Hydrochloride Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Buprenorphine Hydrochloride Industrial Chain Analysis
11.4 Buprenorphine Hydrochloride Market Dynamics
11.4.1 Buprenorphine Hydrochloride Industry Trends
11.4.2 Buprenorphine Hydrochloride Market Drivers
11.4.3 Buprenorphine Hydrochloride Market Challenges
11.4.4 Buprenorphine Hydrochloride Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Buprenorphine Hydrochloride Distributors
12.3 Buprenorphine Hydrochloride Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
